Life Science Innovation Northwest 2024

Leaders from industry and academia come together for a one-of-a-kind panel discussion on the intersection of AI, biotechnology, and life sciences innovation. The panel will explore the frontiers of AI in drug discovery and development, including how tech and pharma are forging new partnerships, the opportunity for AI to shift the way we develop therapies, the challenges on the path toward transformative AI therapies, and strategies for maintaining regional leadership in AI innovation through active engagement of universities and research institutions.

AdvaMed, the national MedTech association, has recently unveiled its new Digital Health Tech Division, aimed at highlighting the pivotal role of data and digital MedTech in revolutionizing healthcare. Shaye Mandle, who leads the new group will moderate a panel of industry leaders from across the country on how digital tools and AI algorithms present new opportunities to improve patient diagnosis and care. The panel will explore the impact of these technologies on improving access to care and enhancing its quality, while also addressing the emerging challenges and policy implications. Join us as experts from both large and small MedTech companies share their strategies and experiences.

Renowned scientist and pioneer in systems biology, proteomics, and P4 Medicine, Dr. Leroy Hood, MD, PhD, will share groundbreaking insights from his new book, “The Age of Scientific Wellness,” sharing how we can revolutionize health and enhance our lives in previously unimaginable ways. Dr. Hood will explore a paradigm shift in healthcare, transitioning from a model focused on treating diseases to one prioritizing wellness and prevention. He will delve into the scientific principles, educational impacts, economic considerations, and political dynamics driving this transformation. He refers to this approach as Radical Health, suggesting a transformative and comprehensive approach to healthcare.

Over the past decade, Washington has developed an innovative biomanufacturing sector and workforce. Unlike other region’s that have used tax incentives to attract large biopharmaceutical operations, Washington’s growth has come from the development of next generation facilities located close to R&D operations as well as the expansion of long-established facilities. In a competitive marketplace, what do we need to maintain the recent growth of biomanufacturing? This panel will explore workforce needs, how to support future innovation, as well as discuss the types of operations that are likely to grown in Washington vs. other regions and what we need to do to support them.

Join us for an insightful panel discussion exploring the post-downturn investment landscape in 2024. Seasoned investors and experts will share valuable insights into recalibrated risk metrics and their strategies for identifying promising early-stage ventures. Panelists will dive into deal values, deal stages, evolving growth and exit strategies, and the rapidly expanding digital landscape. Don’t miss this opportunity to gain nuanced perspectives and seize actionable insights for your startup’s financial journey.

Join us to hear from our esteemed panel of investors as they share their insights on the investment landscape in 2024 and beyond, and gain valuable perspectives on how the Pacific Northwest (PNW) is positioned to drive innovation and shape the future of life sciences. We’ll dive into discussions on the region’s strengths, evolving investor perceptions, and the unique opportunities this community offers. Explore how the PNW compares to long-established hubs like San Francisco and Boston and discover why founders are choosing to build companies in this region.